Pacira BioSciences' Total Current Liabilities fell 6505.3% to $107.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.1 million, marking a year-over-year decrease of 6505.3%. This contributed to the annual value of $309.9 million for FY2024, which is 21824.86% up from last year.
Per Pacira BioSciences' latest filing, its Total Current Liabilities stood at $107.1 million for Q3 2025, which was down 6505.3% from $313.2 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Total Current Liabilities ranged from a high of $521.1 million in Q4 2021 and a low of $92.7 million during Q2 2024
Over the past 5 years, Pacira BioSciences' median Total Current Liabilities value was $147.8 million (recorded in 2022), while the average stood at $203.2 million.
In the last 5 years, Pacira BioSciences' Total Current Liabilities plummeted by 7164.29% in 2022 and then skyrocketed by 23786.17% in 2025.
Pacira BioSciences' Total Current Liabilities (Quarter) stood at $521.1 million in 2021, then tumbled by 71.64% to $147.8 million in 2022, then crashed by 34.1% to $97.4 million in 2023, then skyrocketed by 218.25% to $309.9 million in 2024, then crashed by 65.45% to $107.1 million in 2025.
Its last three reported values are $107.1 million in Q3 2025, $313.2 million for Q2 2025, and $314.7 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value